动物试验
现代化理论
临床试验
药品审批
业务
医学
药理学
工程伦理学
生物技术
法学
政治学
生物
药品
工程类
病理
生态学
出处
期刊:Cancer Discovery
[American Association for Cancer Research]
日期:2023-03-01
卷期号:13 (4): 805-805
被引量:3
标识
DOI:10.1158/2159-8290.cd-nd2023-0001
摘要
The FDA Modernization Act 2.0 allows companies to submit nonanimal data using certain alternative technologies to demonstrate the safety and efficacy of investigational drugs prior to human trials. Animal rights supporters hope the law represents a shift away from animal use, but researchers caution that organ-chips and other innovations, although potentially valuable, cannot replace animal models to test drugs in development.
科研通智能强力驱动
Strongly Powered by AbleSci AI